These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 27262378)
1. Ferulic acid reverses ABCB1-mediated paclitaxel resistance in MDR cell lines. Muthusamy G; Balupillai A; Ramasamy K; Shanmugam M; Gunaseelan S; Mary B; Prasad NR Eur J Pharmacol; 2016 Sep; 786():194-203. PubMed ID: 27262378 [TBL] [Abstract][Full Text] [Related]
2. Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways. Karthikeyan S; Hoti SL; Nazeer Y; Hegde HV Oncotarget; 2016 Jul; 7(27):42353-42373. PubMed ID: 27304668 [TBL] [Abstract][Full Text] [Related]
3. β-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter. Guo HQ; Zhang GN; Wang YJ; Zhang YK; Sodani K; Talele TT; Ashby CR; Chen ZS Oncol Rep; 2014 Feb; 31(2):858-66. PubMed ID: 24284783 [TBL] [Abstract][Full Text] [Related]
4. Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function. Feng SL; Yuan ZW; Yao XJ; Ma WZ; Liu L; Liu ZQ; Xie Y Pharmacol Res; 2016 Aug; 110():193-204. PubMed ID: 27058921 [TBL] [Abstract][Full Text] [Related]
5. Morin reverses P-glycoprotein-mediated multidrug-resistance in KBChR-8-5 cancer cell lines. Zhao Y; Xu S; Hao W; Fu Y Cell Biochem Funct; 2024 Jul; 42(5):e4083. PubMed ID: 38938150 [TBL] [Abstract][Full Text] [Related]
6. PAMAM G4.5 dendrimers for targeted delivery of ferulic acid and paclitaxel to overcome P-glycoprotein-mediated multidrug resistance. Anbazhagan R; Muthusamy G; Krishnamoorthi R; Kumaresan S; Rajendra Prasad N; Lai JY; Yang JM; Tsai HC Biotechnol Bioeng; 2021 Mar; 118(3):1213-1223. PubMed ID: 33289076 [TBL] [Abstract][Full Text] [Related]
7. Esters of the marine-derived triterpene sipholenol A reverse P-GP-mediated drug resistance. Zhang Y; Zhang YK; Wang YJ; Vispute SG; Jain S; Chen Y; Li J; Youssef DT; El Sayed KA; Chen ZS Mar Drugs; 2015 Apr; 13(4):2267-86. PubMed ID: 25874923 [TBL] [Abstract][Full Text] [Related]
8. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe. Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750 [TBL] [Abstract][Full Text] [Related]
9. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169 [TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates. Gupta P; Gao HL; Ashar YV; Karadkhelkar NM; Yoganathan S; Chen ZS Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641875 [TBL] [Abstract][Full Text] [Related]
11. Flavonoids modulate multidrug resistance through wnt signaling in P-glycoprotein overexpressing cell lines. Mohana S; Ganesan M; Rajendra Prasad N; Ananthakrishnan D; Velmurugan D BMC Cancer; 2018 Nov; 18(1):1168. PubMed ID: 30477461 [TBL] [Abstract][Full Text] [Related]
12. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter. Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440 [TBL] [Abstract][Full Text] [Related]
14. Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1. Wang SQ; Liu ST; Zhao BX; Yang FH; Wang YT; Liang QY; Sun YB; Liu Y; Song ZH; Cai Y; Li GF Oncotarget; 2015 Sep; 6(28):26142-60. PubMed ID: 26317651 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and bioevaluation of novel benzodipyranone derivatives as P-glycoprotein inhibitors for multidrug resistance reversal agents. Chen CY; Liu NY; Lin HC; Lee CY; Hung CC; Chang CS Eur J Med Chem; 2016 Aug; 118():219-29. PubMed ID: 27131064 [TBL] [Abstract][Full Text] [Related]
16. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro. Cai P; Lu P; Sharom FJ; Fang WS Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel. Zhu X; Sui M; Fan W Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930 [TBL] [Abstract][Full Text] [Related]
18. Chemosensitizing potential of andrographolide in P-glycoprotein overexpressing multidrug-resistant cancer cell lines. Lakra DS; B P; N D; T D; G K; N RP Nat Prod Res; 2024 Mar; 38(6):941-946. PubMed ID: 37144420 [TBL] [Abstract][Full Text] [Related]
19. Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells. Ma W; Feng S; Yao X; Yuan Z; Liu L; Xie Y Sci Rep; 2015 Dec; 5():18789. PubMed ID: 26689156 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship study of novel 2-aminobenzofuran derivatives as P-glycoprotein inhibitors. Chen CY; Lin CM; Lin HC; Huang CF; Lee CY; Si Tou TC; Hung CC; Chang CS Eur J Med Chem; 2017 Jan; 125():1023-1035. PubMed ID: 27810590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]